| (EUR) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.46M | — |
| Operating expense | — | — |
| Net income | -122.93M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 1CG.F returned +6.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +3.3% |
| 1 year | +6.4% |
| 5 years | +30.2% |
| All-time high | €58.00 (May 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 1CG.F would be worth today ›No. CRISPR Therapeutics AG has not paid a dividend in the past 12 months.
CRISPR Therapeutics AG is part of the Healthcare sector.
CRISPR Therapeutics AG has a market cap of 5.04B EUR, based on the latest quote.
